You just read:

Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting

News provided by

Relmada Therapeutics, Inc.

May 31, 2019, 08:00 ET